BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2968613)

  • 1. The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.
    Hoffman DC; Dickson PR; Beninger RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):315-22. PubMed ID: 2968613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1988 Sep; 31(1):1-8. PubMed ID: 2908061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1989 Jun; 33(2):273-9. PubMed ID: 2573075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.
    Mazurski EJ; Beninger RJ
    Psychopharmacology (Berl); 1991; 105(1):107-12. PubMed ID: 1684056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens.
    White NM; Packard MG; Hiroi N
    Psychopharmacology (Berl); 1991; 103(2):271-6. PubMed ID: 1674160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin.
    Hoffman DC; Wise RA
    Psychopharmacology (Berl); 1993; 110(4):402-8. PubMed ID: 7870909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggestive evidence for a DA D3 receptor-mediated increase in the release of oxytocin in the male rat.
    Uvnäs-Moberg K; Alster P; Hillegaart V; Ahlenius S
    Neuroreport; 1995 Jun; 6(9):1338-40. PubMed ID: 7669999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dopamine receptor involvement in rat feeding behaviour.
    Zarrindast MR; Owji AA; Hosseini-Nia T
    Gen Pharmacol; 1991; 22(6):1011-6. PubMed ID: 1687390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenic homologous supersensitization of quinpirole-induced yawning in rats.
    Kostrzewa RM; Brus R
    Pharmacol Biochem Behav; 1991 Jun; 39(2):517-9. PubMed ID: 1682952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex.
    Ricci A; Collier WL; Rossodivita I; Amenta F
    J Auton Pharmacol; 1991 Apr; 11(2):121-7. PubMed ID: 1675217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR; Eliassi A
    Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N; Nagao T; Ono H
    Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.